February 2023, Mikrocentrum, Veldhoven, The Netherlands
#3dmedical #3dbio #3dmedtech #3ddental #3dpharma
Aprecia Pharmaceuticals announced that SPRITAM® (levetiracetam) tablets, for oral suspension, is now available as an adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures.
SPRITAM is the first prescription drug product approved by the U.S. Food and Drug Administration (FDA) that is manufactured using 3D printing technology. Continue reading “First FDA-Approved 3D Printed Medicine Becomes Available”
3D Printing Ushers in New Era for the Pharmaceutical Industry. Three-dimensional (3D)-printing technology is on track to change the way we make things and drug manufacturing is no exception. After more than two decades of research on the application of 3D printers in drug manufacturing, the FDA has approved for the very first time a drug formulation produced using 3D-printing technology. The approved drug, Spritam (levetiracetam), is a prescription medicine used as an adjunctive therapy in the treatment of seizures in adults and children with epilepsy. Continue reading “3D Printing Ushers in New Era for the Pharmaceutical Industry”